
China's biotechnology sector shifts from manufacturing to exploring pharma innovation
China's biotechnology sector is expanding its role in the global pharmaceutical industry, moving beyond the manufacturing of conventional medicines and pharmaceutical ingredients to the development and international licensing of innovative drugs, as growing demand for Chinese-developed therapies creates new opportunities for international research and commercial partnerships.



_20260126115701440_af4631%20(3)_20260914115350308_11eb60.webp)












.png)
















.jpg)













































_20260909054021554_9b5681.webp)





